Difference between revisions of "Team:ETH Zurich/Achievements"

Line 41: Line 41:
 
<li><img src="https://static.igem.org/mediawiki/2015/5/51/ETH15_Bronze_medal.png" align="right" width="1.8%">We designed 8 synthetic <a href="https://2015.igem.org/Team:ETH_Zurich/Part_Collection">LldR dependent promoters</a> and characterized them. Additionally, the influence of the lacate importer LldP was characterized.</li>
 
<li><img src="https://static.igem.org/mediawiki/2015/5/51/ETH15_Bronze_medal.png" align="right" width="1.8%">We designed 8 synthetic <a href="https://2015.igem.org/Team:ETH_Zurich/Part_Collection">LldR dependent promoters</a> and characterized them. Additionally, the influence of the lacate importer LldP was characterized.</li>
  
<li><img src="https://static.igem.org/mediawiki/2015/9/9b/ETH15_Gold_medal.png" align="right" width="1.8%">We characterized parts of the natural <i>E. coli</i> <a href="https://2015.igem.org/Team:ETH_Zurich/Results#Characterization_of_the_LldR_promoter">lldPRD-operon</a>, on which there is only a very limited amount of information present in the literature.</li>
+
<li><img src="https://static.igem.org/mediawiki/2015/9/9b/ETH15_Gold_medal.png" align="right" width="1.8%">We characterized parts of the natural <i>E. coli</i> <a href="https://2015.igem.org/Team:ETH_Zurich/Results#Characterization_of_the_LldR_promoter">lldPRD-operon</a>, on which there is only a limited amount of information present in the literature.</li>
  
 
<li><img src="https://static.igem.org/mediawiki/2015/9/9b/ETH15_Gold_medal.png" align="right" width="1.8%">We documented and submitted two new <a href="https://2015.igem.org/Team:ETH_Zurich/Basic_Part">basic parts</a> to the iGEM parts registry and created a <a href="https://2015.igem.org/Team:ETH_Zurich/Part_Collection">part collection</a> with 14 parts.</li>
 
<li><img src="https://static.igem.org/mediawiki/2015/9/9b/ETH15_Gold_medal.png" align="right" width="1.8%">We documented and submitted two new <a href="https://2015.igem.org/Team:ETH_Zurich/Basic_Part">basic parts</a> to the iGEM parts registry and created a <a href="https://2015.igem.org/Team:ETH_Zurich/Part_Collection">part collection</a> with 14 parts.</li>
  
<li>We designed a <a href="https://2015.igem.org/Team:ETH_Zurich/Chip">chip</a> for later easy application of our MicroBeacon <i>E. coli</i>.</li>
+
<li>We designed a <a href="https://2015.igem.org/Team:ETH_Zurich/Chip">chip</a> for future application of our MicroBeacon <i>E. coli</i>.</li>
  
 
<li>We participated in the <a href="https://2015.igem.org/Team:ETH_Zurich/Interlab_study">interlab study</a>.</li>
 
<li>We participated in the <a href="https://2015.igem.org/Team:ETH_Zurich/Interlab_study">interlab study</a>.</li>
Line 54: Line 54:
 
<h3>Modeling Achievements</h3>
 
<h3>Modeling Achievements</h3>
  
<ul><li>By modeling the system we showed that <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling#Conclusions">the system as a whole can work</a>.</li></ul>
+
<ul>
 +
 
 +
<li>We separately modeled two different signals of our cancer detection system, the <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/Lactate_Module">Lactate Module</a> and the <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/AHL_Module"> AHL Module</a>.</li>
 +
 
 +
<li> We defined and estimated <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/Parameters">all relevant parameters for our models</a>.</li>
 +
 
 +
<li>We integrated the two modules into a <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/Single-cell_Model">Combined Compartment Model</a> to simulate a logical AND gate.</li>
 +
 
 +
<li>To account for the diffusion and degradation of signaling molecules under real-world conditions we designed various <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/Reaction-diffusion">Reaction-diffusion Models</a>.</li>
 +
 
 +
<li>We optimized our model by <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/Experiments_Modelintegrating">integrating experimental data</a> gathered by the characterization of our LldR promoter constructs.</li>
 +
 
 +
<li>We showed that the successful detection of cancer cells with our system <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling#Conclusions">is feasible in principle</a>.</li>
 +
 
 +
</ul>
  
 
<p></p>
 
<p></p>

Revision as of 09:02, 18 September 2015

"What I cannot create I do not understand."
- Richard Feynmann

Achievements

We are proud to announce that we achieved the following goals

General Achievements

Experimental Achievements

  • We designed a novel system for detection of circulating tumour cells in blood samples using genetically modified bacteria.
  • We designed a genetic circuit that integrates two different cancer specific signals (lactate and AHL)in an AND gate.
  • We implemented a method to do single cell analysis of cancer cells by expressing Annexin V in the E. coli outer membrane, which enables them to selectively bind to apoptotic cancer cells.
  • We designed 8 synthetic LldR dependent promoters and characterized them. Additionally, the influence of the lacate importer LldP was characterized.
  • We characterized parts of the natural E. coli lldPRD-operon, on which there is only a limited amount of information present in the literature.
  • We documented and submitted two new basic parts to the iGEM parts registry and created a part collection with 14 parts.
  • We designed a chip for future application of our MicroBeacon E. coli.
  • We participated in the interlab study.
  • Our experiments complied with the safety instructions at the Department of Biosystems Science and Engineering D-BSSE in Basel where our lab is situated.

Modeling Achievements

Human Practices Achievements

Medal Criteria

Register for iGEM, have a great summer, and attend the Giant Jamboree. Going for it!
Complete the Judging Form
Create a Description of the team's project
Document the team's parts using the Registry of Standard Biological Parts
Present a poster and a talk at the iGEM Jamboree. Going for it!
Create a page on your team wiki with clear attribution of each aspect of your project.
Document one new standard BioBrick Part or Device
Experimentally validate that at least one new BioBrick Part of your own design
Submit this new part to the iGEM Parts Registry.
Human Practices in iGEM. Demonstrate how your team has identified, investigated and addressed one or more of these issues in the context of your project.
Expand on your silver medal Human Practices activity
Help another university to characterize a part
Improve the characterization of a previously existing BioBrick Part or Device

We would like to thank our sponsors